Qualio

Qualio is a provider of cloud-based quality management software (eQMS) for the life sciences industry. Founded in 2012 by Robert Fenton, the company serves over 700 customers across 80+ countries including medical device manufacturers, pharmaceutical companies, biotechnology firms, cannabis businesses, and contract research and manufacturing organizations.

The company operates as a fully remote organization with 118 employees headquartered in San Francisco. Qualio has raised $63.9 million in total funding, with the most recent Series B round of $50 million in May 2021 led by Tiger Global Management. Qualio states its mission as accelerating life science teams to faster launches, smarter scaling and seamless compliance through an integrated, AI-powered quality management platform.

Qualio serves the broader life sciences industry including pharmaceuticals, biotech, medical devices, and contract manufacturing organizations. The company maintains a dedicated pharmaceutical solutions page and offers pharma-specific workflows, compliance tools, and features including pharmacovigilance event management, ICH Q10 toolkit, and GxP-compliant processes for FDA, EMA, and ICH requirements.

Named pharmaceutical customers include AGADA Biosciences, LogixX Pharma, iMIX, and Medinatura, along with biotech companies such as Helix Biotech, VitaCyte, Enara Bio, Vector BioMed, and Expression Therapeutics. The founder's background includes quality and R&D roles at global pharmaceutical companies Pfizer and Leo Pharma. Qualio supports the drug lifecycle from development through post-market activities with pharma-optimized configurations, though it is not a pharma-only vendor and serves multiple life science sectors.

Qualio has raised $63.9 million in total funding across 5 rounds from 12 investors. The most recent funding was a $50 million Series B round in May 2021 led by Tiger Global Management, with participation from Menlo Ventures and existing investors including Frontline Ventures, MHS Capital, Operator Partners, Sorenson Ventures, and Storm Ventures. Earlier rounds included Series A funding from Storm Ventures and Sorenson Capital in July 2020, and seed funding from 500 Global and Enterprise Ireland in 2016.

The investor roster includes firms that have previously backed major technology companies including Facebook, Spotify, Uber, and Stripe. As a privately held company, Qualio does not publicly disclose annual revenue or profitability status. The Series B funding was intended to expand accessibility of their eQMS software and services for life sciences customers at global scale and invest in product and engineering team growth.

Qualio offers a single, integrated cloud-based quality management system rather than a suite of separate products. The platform comprises nine core modules unified in one system: document management, design controls, risk management (ISO 14971, ICH Q9), training management, change control, audit management, CAPA and nonconformance management, supplier management, and AI-powered compliance intelligence.

Cross-module workflows link documents, training, changes, and quality events. Recent innovations include AI capabilities through the Qualio AI Assistant and Compliance Intelligence tool. The platform is built on "Qualio's 6 pillars of quality" framework designed to establish comprehensive quality and compliance structures. Qualio is architected as a cloud-native SaaS solution with no on-premise deployment option, focusing on accessibility, ease of use, and rapid implementation for growing life science companies.

Qualio maintains a dedicated integrations page for connecting with key business-critical applications, but its technology partners are undisclosed. The platform describes integration capabilities linking to complementary business systems used by life science companies.

No implementation or consulting partner network is disclosed. Implementation support is delivered directly, in-house, through the company's customer success and professional services teams. Industry affiliations and strategic technology partnerships beyond general integration capabilities are also undisclosed.

Qualio provides global weekday support via chat and email channels, with an extensive knowledge base available for self-service support and training resources. Implementation services include dedicated preparation averaging 30–60 days, with white-glove validation services featuring a comprehensive validation pack containing templated validation documentation, protocols, and guidance to accelerate customer validation efforts.

Professional services encompass implementation support, validation assistance for FDA and ISO compliance, migration services from paper-based and legacy systems, and comprehensive training programs. Customer testimonials highlight support quality, with Qualio earning a 9.1/10 rating for quality of support on G2. The company emphasizes rapid onboarding and continuous customer success, with multiple customers reporting achievement of ISO certifications within 7–9 months from initial contact.

Qualio maintains ISO 9001 certification for quality management and ISO 27001 certification for information security. The company has received substantial industry recognition including G2 awards for Most Impactable eQMS for Growing Life Science Companies (Results Index score 8.45) and Most Implementable eQMS across the entire quality management category in 2025.

Leadership includes Founder & CEO Robert Fenton, who brings pharmaceutical industry expertise from quality and R&D roles at Pfizer and Leo Pharma following pharmacy education at University College Cork. Additional executives include Kevin Duggan (Engineering & Product) and Christelle Hochart (People Operations). Qualio publishes a blog with compliance guidance, implementation best practices, and regulatory updates.

Qualio maintains an actively updated website with a comprehensive resource center featuring blog articles, compliance checklists, guides, and educational content. The most recent company blog post announcing G2 awards was published in early 2025, with regular press releases documenting funding rounds and company milestones. The company has 15,713 LinkedIn followers and frequent posting activity, including posts from the last week covering quality culture, pharmaceutical technology podcasts, and compliance topics.

The platform offers product demos. A free trial is undisclosed on the pricing page. Qualio positions itself as "#1 Cloud-based Quality Management Software" and is prominently featured in QMS comparison guides, review platforms, and software directories. The company publishes extensive educational content including downloadable compliance checklists (21 CFR Part 11), guides for medical device manufacturers and clinical trials, and industry-specific best practices.